Dr. Ankita

My research focuses on the exploration of metabolic enzymes, cellular pathways, and diet-dependent regulatory mechanisms involved in Helicobacter pylori infection. The overarching goal is to employ Biochemistry and Molecular Biology approaches to investigate the basis of Helicobacter pylori infection and its association with cancer development. The broader objective is to identify and characterize novel targets and inhibitors that may serve as potential therapeutic interventions. I earned my doctoral degree from the Special Centre for Molecular Medicine (SCMM), Jawaharlal Nehru University. My academic training includes postgraduate studies from the Special Centre for Molecular Medicine (SCMM), Jawaharlal Nehru University, and undergraduate studies in Biochemistry from Sri Venkateswara College, University of Delhi. 

• Assistant Professor in University School of Biotechnology at Guru Gobind Singh Indraprastha University, New Delhi.
• DBT Research Associate in Protein Engineering Laboratory at National Institute of Immunology, New Delhi.
• Faculty at Pathfinder Academy, New Delhi. 
• Postdoctoral Research Associate at Washington University in St. Louis School of Medicine, Missouri, USA.

Biochemistry

Cell Biology

Pharmacogenomics and Personalised Medicine

• Tehlan, A., Nagar, P., Prajapati, R., Bhowmick, K., Kumar, A., Kaur, I., Subbarao, N., & Dhar, S. K. (2025). Plasmodium falciparum acetyltransferase GCN5 acts as a dual regulator of essential glycolytic enzyme phosphoglycerate mutase. The FEBS journal, 292(20), 5506–5524. 
• Tehlan, A., Saha, A. & Dhar, S. K. (2023). Targeting proteases and proteolytic processing of unusual N-terminal extensions of Plasmodium proteins: parasite peculiarity. Frontiers in Drug Discovery, 3. 
• Tehlan, A., Bhowmick, K., Kumar, A., Subbarao, N., & Dhar, S. K. (2022). The tetrameric structure of Plasmodium falciparum phosphoglycerate mutase is critical for optimal enzymatic activity. The Journal of Biological Chemistry, 298(3), 101713.
• Tehlan, A., Karmakar, B. C., Paul, S., Kumar, R., Kaur, I., Ghosh, A., Mukhopadhyay, A. K., & Dhar, S. K. (2020). Antibacterial action of acriflavine hydrochloride for eradication of the gastric pathogen Helicobacter pylori. FEMS Microbiology Letters, 367(21), fnaa178.
• Bhowmick, K., Tehlan, A., Sunita, Sudhakar, R., Kaur, I., Sijwali, P. S., Krishnamachari, A., & Dhar, S. K. (2020). Plasmodium falciparum GCN5 acetyltransferase follows a novel proteolytic processing pathway that is essential for its function. Journal of Cell Science, 133(1), jcs236489.

Filed an Indian Patent relating to “ACRIFLAVINE HYDROCHLORIDE AS A POTENT HELICOBACTER PYLORI GROWTH INHIBITOR” in 2020 as a co-applicant. Current status- Published.

 

• Awarded DST-Inspire Faculty Fellowship (Call 2024). 
• Awarded DBT-Research Associate fellowship (2023).
• Awarded CSIR SRF in Life Sciences (2019-2021) and CSIR JRF in Life Sciences (2017-2019), AIR 38.
• Qualified Graduate Aptitude Test in Engineering (GATE)-Life Sciences in 2020.

Faculty Development Program on Course File Preparation and Question Paper Setting based on OBE, organized by Delhi Technological University in association with NITTTR Chennai (13th-17th October 2025).

LinkedIn: https://www.linkedin.com/in/ankita-tehlan-phd-a08014216/

ORCID: 0000-0002-3471-4226